International Cognition and Cancer Task Force recommendations to harmonise studies of cognitive function in patients with cancer.
about
Interventions for preventing and ameliorating cognitive deficits in adults treated with cranial irradiationNon-pharmacological interventions for cognitive impairment due to systemic cancer treatmentNon-pharmacological interventions for cognitive impairment due to systemic cancer treatmentChemotherapy-related cognitive impairment in older patients with cancerEffects of Exercise Interventions and Physical Activity Behavior on Cancer Related Cognitive Impairments: A Systematic ReviewCancer- and cancer treatment-associated cognitive change: an update on the state of the scienceChemobrain: a critical review and causal hypothesis of link between cytokines and epigenetic reprogramming associated with chemotherapyA systematic review and meta-analysis of changes in cognitive functioning in adults undergoing hematopoietic cell transplantationEmerging pharmacotherapy for cancer patients with cognitive dysfunctionCancer survivorship: current status of research, care, and policy in JapanLong term side effects of adjuvant chemotherapy in patients with early breast cancerPerceived Stress Levels, Chemotherapy, Radiation Treatment and Tumor Characteristics Are Associated with a Persistent Increased Frequency of Somatic Chromosomal Instability in Women Diagnosed with Breast Cancer: A One Year Longitudinal StudyPotential epigenetic mechanism(s) associated with the persistence of psychoneurological symptoms in women receiving chemotherapy for breast cancer: a hypothesisWhat is known and unknown about chemotherapy-related cognitive impairment in patients with haematological malignancies and areas of needed research.Long-term trajectories of self-reported cognitive function in a cohort of older survivors of breast cancer: CALGB 369901 (Alliance).Cognitive function and breast cancer: promise and potential insights from functional brain imaging.Opening up the window into "chemobrain": a neuroimaging reviewFunctional MRI studies in non-CNS cancers.Default mode network as a potential biomarker of chemotherapy-related brain injuryCognitive complaints in cancer: The French version of the Functional Assessment of Cancer Therapy-Cognitive Function (FACT-Cog), normative data from a healthy population.Chemotherapy and Cognitive Function in Breast Cancer Patients: The So-Called Chemo Brain.Verbal fluency in breast cancer patients treated with chemotherapy.Cognitive impairment in older patients with breast cancer before systemic therapy: is there an interaction between cancer and comorbidity?A prospective study of cognitive function in men with non-seminomatous germ cell tumors.Reply to F. Tomao et al.Prevalence, mechanisms, and management of cancer-related cognitive impairment.A meta-analysis of cognitive impairment following adult cancer chemotherapy.A prospective study of grey matter and cognitive function alterations in chemotherapy-treated breast cancer patients.Neuromarkers of fatigue and cognitive complaints following chemotherapy for breast cancer: a prospective fMRI investigation.Early measures of cognitive function predict survival in patients with newly diagnosed glioblastoma.Meta-analysis of cognitive functioning in breast cancer survivors previously treated with standard-dose chemotherapy.Longitudinal assessment of cognitive changes associated with adjuvant treatment for breast cancer: the impact of APOE and smokingNeurotoxic Effects of Anthracycline- vs Nonanthracycline-Based Chemotherapy on Cognition in Breast Cancer Survivors.Cognitive function and fatigue after diagnosis of colorectal cancerMonitoring and optimising cognitive function in cancer patients: Present knowledge and future directions.Cancer- and treatment-related cognitive changes: what can we do now? What lies ahead?Memory loss during lenalidomide treatment: a report on two casesCytokines as mediators of chemotherapy-associated cognitive changes: current evidence, limitations and directions for future researchClinical characteristics, pathophysiology, and management of noncentral nervous system cancer-related cognitive impairment in adultsNeuropsychological assessment of individuals with brain tumor: comparison of approaches used in the classification of impairment.
P2860
Q24187244-E70FAD04-961C-443C-A58F-9DCE8E57B991Q24193350-AA20F59E-D3D9-4C7A-9F96-B9834E746CD3Q26470426-C4806191-A9BF-486B-8303-5A358668784EQ26747612-8288532D-B1BB-4C5C-9384-83CD732256CBQ26752851-50F337B2-D9D9-4269-8BD0-F33C746FB764Q26853289-FA2F84DA-4CA0-4DE5-8621-5A5A023BAA81Q27011451-4A9019B8-0090-4453-AB22-21B0321B2D48Q27013566-B2459A1D-DDF6-4DB0-B57A-771F722BCA2AQ27026729-43F14E72-47E4-4FE4-88CA-8CED082084DFQ28066998-FF505DA1-55A7-4B86-B1B5-F4A3BCC924D0Q28083233-0ED133C4-8D53-4A38-9E2F-4E8051B2614CQ28383479-5AFE2583-B2BA-42ED-8A74-2707FEAD9F4AQ28393302-C885C1A4-37F8-4FA4-8A02-5BC951701C41Q30249112-F007BA96-F801-4E9B-BAB1-8E99E78A2D93Q30489606-6AF8E971-6A6B-4D24-BD53-1A890111C01DQ30572890-73B53139-CFA6-4608-9429-77A2A160BCE1Q30596880-4C855244-1B12-4CAC-B52A-7FF1A117AAD3Q30660824-FECBDE42-3DE9-4161-95C6-E0D5A8D30109Q30830124-400545CB-DEB3-4ED4-83C3-62E13D83AAF0Q30945359-FB403BB0-A6AD-44F0-A753-4675243FF802Q33360883-3B4738D8-C106-4908-9F3A-B8D552D83CAEQ33575742-B3EE27E6-337B-4E5B-A9EF-D33B08C105C9Q33729085-C4662B33-1603-4A42-A7AC-99839E17B5FAQ33790550-BCCF77AA-E3AC-46B1-B7B4-345B0872A6FEQ33816570-ACA8D098-F2ED-41E8-B4A2-836856CD5306Q33854977-0FB9B5BF-B065-40D7-9D43-6F2A38A28934Q34083459-83FEB96F-6649-4F36-832E-45F75985FF47Q34110937-B452F7B3-02EF-47AA-B5FF-7DAD7C0F7189Q34194470-FE4425ED-631A-48B7-9EE0-10E99B8A0569Q34234748-C3D32E92-D003-4F5E-A40E-3D3CB787BDD2Q34395112-EE35E58B-B903-4614-8160-7B9CCB33B8C3Q34429393-63E27DDC-D87E-4A36-A3C8-745CC31B7133Q34503992-8EA74F55-3619-4A49-9655-55FCAB604EB8Q34553654-D79371A9-6EF2-46EF-8519-2AFAFD59E52CQ34604438-4522E2CB-C439-4214-A6FD-01A69D996C0BQ34669341-988B7E1D-368A-447C-9D97-9FBC0A281CB9Q34929303-D91737AE-1766-41CF-A766-9DC2BDCC9CC5Q35067446-04F8E7A8-FD93-4B4C-B262-AE9BD8CEC032Q35164117-CC20BF68-2055-4B06-A8F0-FA3331E99072Q35166810-7B5FCF1C-81B0-4D19-8971-AD8CE596FF43
P2860
International Cognition and Cancer Task Force recommendations to harmonise studies of cognitive function in patients with cancer.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh-hant
name
International Cognition and Ca ...... ction in patients with cancer.
@en
International Cognition and Ca ...... ction in patients with cancer.
@nl
type
label
International Cognition and Ca ...... ction in patients with cancer.
@en
International Cognition and Ca ...... ction in patients with cancer.
@nl
prefLabel
International Cognition and Ca ...... ction in patients with cancer.
@en
International Cognition and Ca ...... ction in patients with cancer.
@nl
P2093
P1433
P1476
International Cognition and Ca ...... ction in patients with cancer.
@en
P2093
Jeffrey S Wefel
Sanne B Schagen
P304
P356
10.1016/S1470-2045(10)70294-1
P577
2011-02-25T00:00:00Z